Ms. Ameera Shah - MD Promoter & CEO, Metropolis Healthcare Ltd.
"Ms. Shah has evolved Metropolis from its single pathology laboratory status to a fully integrated multinational chain of 125 diagnostic centers and 800 collection centers across the globe. Metropolis delivers over 15 million tests a year, catering to more than 10,000 Laboratories, Hospitals, Nursing homes and 2,00,000 Consultants. With 33 years of experience in delivering accurate reports, Metropolis has earned the reputation of being India's leading and only multinational chain of diagnostic centres with presence in UAE, Sri Lanka, South Africa, Kenya, Mauritius and Ghana."
"Under her leadership, Metropolis has been the first to create a sustainable business model for pathology, the first to traverse in to emerging markets & the first to implement global standards of quality in all its processes & systems."
Old News starting to pan out for Radient...
Radient Pharmaceuticals Expects to See Benefits From Previously Undisclosed New Major Partnership in India
Dr. Umesh Bhatia, Ph.D, senior advisor for the Onko-Sure for Radient Pharmaceuticals' (NYSE Amex: RPC) operations in India, has revealed that his group has secured a major new partnership that should clearly benefit Radient and is expected to impact the company's bottom line.
"In addition, we have teamed up with another government screening program in another major cancer hospital (Metropolis) and are in very late-stage talks with them to do a joint banner program with them, this time in Southern India. This is all positive news, but I think the message here is that the efforts in India are focused on the long term success for Onko-Sure and that we all remain steadfast in our progress."
AI
